Scancell (LON:SCLP) Trading Down 5.2% – Here’s What Happened

Scancell Holdings plc (LON:SCLP)’s share price was down 5.2% on Wednesday . The company traded as low as GBX 10 ($0.13) and last traded at GBX 10.90 ($0.15). Approximately 2,669,612 shares were traded during mid-day trading, an increase of 172% from the average daily volume of 980,022 shares. The stock had previously closed at GBX 11.50 ($0.15).

Scancell Trading Down 0.9 %

The company has a 50 day moving average of GBX 8.93 and a two-hundred day moving average of GBX 10.68. The company has a debt-to-equity ratio of -566.79, a quick ratio of 13.01 and a current ratio of 3.42. The stock has a market capitalization of £110.34 million, a PE ratio of -16.33 and a beta of 0.35.

Scancell (LON:SCLP) last posted its quarterly earnings data on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share (EPS) for the quarter. Sell-side analysts predict that Scancell Holdings plc will post -2.5361112 EPS for the current year.

About Scancell

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.